首页|大剂量甲氨蝶呤致MTHFR突变患者甲氨蝶呤排泄延迟及肝损害1例

大剂量甲氨蝶呤致MTHFR突变患者甲氨蝶呤排泄延迟及肝损害1例

扫码查看
该文介绍1例MTX代谢和排泄基因突变的儿童ALL患者在接受HD-MTX化疗后联合应用PPI和青霉素类药物导致肝损害的过程.该案例可为存在MTX代谢和排泄基因突变的患者以及类似联合用药患者提供一定的参考.通过该案例,建议患者在应用HD-MTX化疗前进行MTX用药基因检测,根据基因检测结果提前适当增减HD-MTX 的用量,密切监测血药浓度,减少或避免联合应用PPI和青霉素类等可能影响MTX排泄的药物,避免发生MTX排泄延迟或毒副反应.
Methylenetetrahydrofolate reductase mutation with delayed methotrexate excretion and liver damage caused by high-dose methotrexate:one case report
This report described the process of liver dam-age caused by a combined dosing of proton pump inhibitor(PPI)and penicillin in an ALL child with MTX metabolism and excretion gene mutations after receiving high-dose metho-trexate(HD-MTX)chemotherapy.It provided some refer-ence for patients with MTX metabolism and excretion gene mutations,as well as similar combination therapy patients.Therefore methylenetetrahydro folate reductase(MTHFR)C677T,MTHFR A1298C and ABCB1 C3435T genotyping are recommended to perform before HD-MTX chemo-therapy.Based upon the results of genotypic analyses,the dosage of HD-MTX should be appropriately adjusted in advance.Blood concentration of MTX should be closely monitored for avoiding a combined dosing of PPI and penicil-lin potentially affecting MTX excretion to prevent delayed MTX excretion or adverse drug reaction.

high-dose methotrexatedelayed excretionliver damagegenetic polymorphismdrug combination

李晓、全香花、徐文、张小蕾、李静

展开 >

青岛大学附属医院药学部,山东青岛 266003

大剂量甲氨蝶呤 排泄延迟 肝损害 基因多态性 联合用药

2024

中国医院药学杂志
中国药学会

中国医院药学杂志

CSTPCD北大核心
影响因子:1.198
ISSN:1001-5213
年,卷(期):2024.44(14)
  • 17